Picture of Delta-Fly Pharma logo

4598 — Delta-Fly Pharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: Delta-Fly Pharma - 6-MTH parent results

Nov 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Sep 30, 2025        Sep 30, 2024       Mar 31, 2026  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Operating     loss 831 mln        loss 916 mln        loss 1.50    
  Recurring     loss 840 mln        loss 915 mln        loss 1.51    
  Net           loss 841 mln        loss 917 mln        loss 1.51    
  EPS          loss 77.04 yen      loss 111.44 yen   loss 155.45 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T

Recent news on Delta-Fly Pharma

See all news